Five years of progress for International Journal of Cardiology.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2005.03.002PMID 15561316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Body surface potential mapping improves detection of ST segment alteration during percutaneous coronary intervention.

  2004cited by this paper
• Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC.

  2004cited by this paper
• Adult congenital heart disease in the International Journal of Cardiology.

  2003cited by this paper
• Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization.

  2003cited by this paper
• Aerobic exercise physiology in a professional rugby union team.

  2003cited by this paper
• Circadian heart rate and blood pressure variability considered for research and patient care.

  2003cited by this paper
• Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?

  2003cited by this paper
• Secondary prevention in coronary heart disease patients with low HDL: which options do we have?

  2003cited by this paper
• Current concepts of cardiovascular diseases in diabetes mellitus.

  2003cited by this paper
• Endothelium and the lipid metabolism: the current understanding.

  2003cited by this paper
• Beneficial effects of betaxolol, a selective antagonist of beta-1 adrenoceptors, on exercise-induced myocardial ischemia in patients with coronary vasospasm.

  2003cited by this paper
• Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations.

  2003cited by this paper
• Familial hypercholesterolemia--improving treatment and meeting guidelines.

  2003cited by this paper
• International Society for Adult Congenital Cardiac Disease: an introduction to the readership and an invitation to join.

  2003cited by this paper
• Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease.

  2002cited by this paper
• Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.

  2002cited by this paper
• Beyond lipid lowering: the role of statins in vascular protection.

  2002cited by this paper
• Chronic heart failure and skeletal muscle catabolism: effects of exercise training.

  2002cited by this paper
• Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.

  2002cited by this paper
• Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

  2002cited by this paper
• The prevalence of anemia in chronic heart failure.

  2002cited by this paper
• Omapatrilat--the story of Overture and Octave.

  2002cited by this paper
• Cachexia: a therapeutic approach beyond cytokine antagonism.

  2002cited by this paper
• How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.

  2002cited by this paper
• Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease.

  2002cited by this paper
• New insights in the transcriptional activity and coregulator molecules in the arterial wall.

  2002cited by this paper
• Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion.

  2002cited by this paper
• The syndrome of cardiac cachexia.

  2002cited by this paper
• Cytokines, apoptosis and cachexia: the potential for TNF antagonism.

  2002cited by this paper

• How to relevantly measure the relevance of published articles?

  2007cites this paper
• Top of the charts: download versus citations in the International Journal of Cardiology.

  2005cites this paper